How Blood Viscosity Testing May Help Monitor Cognitive Decline
Blood Viscosity & Cognitive Decline: What Aging Brains Need
Cerebral perfusion • Processing speed & memory • Objective monitoring with WBV
Recent research suggests that blood viscosity (WBV)—the thickness and stickiness of blood—may be a key indicator of cognitive decline risk. Meridian Valley Lab’s Whole Blood Viscosity Test helps clinicians proactively assess cerebral circulation by measuring how efficiently blood can reach the brain.
Higher viscosity → lower cognition: In community-dwelling older adults, elevated WBV correlated with poorer memory, reasoning, and processing speed—even after adjusting for age.[1]
Why Viscosity Matters for Brain Function
Show Section
As blood thickens, flow slows and vascular resistance rises. The brain receives less oxygen and fewer nutrients, compromising synaptic efficiency and neurovascular coupling. Over time this can present as forgetfulness, slower thinking, and reduced mental sharpness.
- Hemodynamic load: Higher WBV increases total peripheral resistance, straining macro- and microcirculation.
- Microvascular delivery: Low-shear (diastolic) conditions accentuate RBC aggregation—critical for capillary-level perfusion in the brain.
Longitudinal Evidence: The Edinburgh Artery Study
Show Findings
Among 452 older adults, higher baseline WBV predicted lower performance in memory, reasoning, and processing speed; the association with general cognitive function remained significant after age adjustment (p<0.01). Verbal fluency was the only domain not significantly affected.[1]
Aging & Viscosity: A Manageable Trend
Show Section
In healthy males aged 16–80, WBV rose progressively with age—independent of overt disease—highlighting a baseline trajectory that may elevate long-term brain and cardiovascular risk.[2]
Why Monitor WBV in Cognitive Care?
Show Section
- Only test of flow resistance: WBV directly measures the resistance of blood in motion, not just surrogate factors.
- Pre-symptom screening: Identify elevated flow resistance before cognitive complaints emerge.
- Therapy tracking: Assess response to interventions aimed at improving perfusion (hydration/electrolytes, omega-3s, activity, inflammation control).
About MVL’s Whole Blood Viscosity Test
Show Details
- Method: Calibrated glass capillary system measuring systolic (high-shear) and diastolic (low-shear) WBV
- Regulatory: FDA-registered Class I instrument (21 CFR § 862.2920)
- Billing: Not covered by insurance; physicians bill patients/caregivers directly
Important Interpretation Notes
Measured parameter, not diagnosis: MVL reports whole blood viscosity to inform clinical decision-making. Results must be interpreted by licensed clinicians within the context of history, exam, and other labs.
Support Brain Health with Objective Flow Metrics
Show CTA
Practitioners: Add WBV to cognitive-risk workups and track pre/post intervention change. Contact Client Services to order or discuss interpretation.
Patients: Ask your licensed provider whether WBV testing fits your prevention or treatment plan. Meridian Valley Lab provides laboratory services only and cannot advise patients directly.
Call: 855.405.8378 | 206.209.4200
References
Show References
- Rafnsson S, Deary IJ, Whiteman MC, Rumley A, Lowe GD, Fowkes FG. Haemorheological predictors of cognitive decline: the Edinburgh Artery Study. Age Ageing. 2010;39:217–22.
- Lowe GD, Drummond MM, Forbes CD, Barbenel JC. The effects of age and cigarette-smoking on blood and plasma viscosity in men. Scott Med J. 1980;25:13–7.
